Kuzhan O - Search Results

1

CA-125; a new marker for diagnosis and follow-up of patients with tuberculous peritonitis.

Mas MR, Cömert B, Sağlamkaya U, Yamanel L, Kuzhan O, Ateşkan U, Kocabalkan F. Mas MR, et al. Among authors: kuzhan o. Dig Liver Dis. 2000 Oct;32(7):595-7. doi: 10.1016/s1590-8658(00)80841-5. Dig Liver Dis. 2000. PMID: 11142557

2

Insulin resistance in non-alcoholic steatohepatitis.

Cömert B, Mas MR, Erdem H, Dinc A, Saglamkaya U, Cigerim M, Kuzhan O, Unal T, Kocabalkan F. Cömert B, et al. Among authors: kuzhan o. Dig Liver Dis. 2001 May;33(4):353-8. doi: 10.1016/s1590-8658(01)80091-8. Dig Liver Dis. 2001. PMID: 11432515

3

Some sociodemographic and diagnostic characteristics of military patients treated in the Department of Medical Oncology, Gülhane Military Medical Academy.

Acikel CH, Kir T, Komurcu S, Kilic S, Ozett A, Rzayev M, Arpaci F, Ozturk B, Ogur R, Ataergin S, Kuzhan O, Hasde M. Acikel CH, et al. Among authors: kuzhan o. Mil Med. 2006 May;171(5):420-4. doi: 10.7205/milmed.171.5.420. Mil Med. 2006. PMID: 16761893

4

Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer.

Kuzhan O, Ozet A, Ulutin C, Kömürcü S, Arpaci F, Oztürk B, Oztürk M. Kuzhan O, et al. Tumori. 2007 Nov-Dec;93(6):550-6. doi: 10.1177/030089160709300606. Tumori. 2007. PMID: 18338488

5

Stem cell mobilization by G-CSF in solid and hematological malignancies: single daily dose is better than split dose in obese patients.

Cetin T, Arpaci F, Ozet A, Oztürk B, Kömürcü S, Ihsan Uzar A, Yilmaz I, Beyzadeoĝlu M, Oysul K, Ataergin S, Kuzhan O, Pekel A. Cetin T, et al. Among authors: kuzhan o. J Clin Apher. 2003;18(3):120-4. doi: 10.1002/jca.10068. J Clin Apher. 2003. PMID: 14569602

6

Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.

Kuzhan O, Ozet A, Ulutin C, Kurt B, Komurcu S, Ozturk B, Ataergin S, Gunhan O. Kuzhan O, et al. Saudi Med J. 2007 Sep;28(9):1374-9. Saudi Med J. 2007. PMID: 17768463

7

Primary glioblastoma multiforme in younger patients: a single-institution experience.

Ulutin C, Fayda M, Aksu G, Cetinayak O, Kuzhan O, Ors F, Beyzadeoglu M. Ulutin C, et al. Among authors: kuzhan o. Tumori. 2006 Sep-Oct;92(5):407-11. doi: 10.1177/030089160609200507. Tumori. 2006. PMID: 17168433

8

The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer.

Arpaci F, Safali M, Ozet A, Ural AU, Cetin T, Ozturk M, Ataergin S, Kuzhan O, Komurcu S, Ozturk B, Acikel C. Arpaci F, et al. Among authors: kuzhan o. J Clin Apher. 2009;24(5):197-204. doi: 10.1002/jca.20211. J Clin Apher. 2009. PMID: 19816961 Clinical Trial.

9

The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS.

Arpaci F, Cetin T, Ozet A, Oysul K, Pekel A, Ataergin S, Kuzhan O, Kömürcü S, Oztürk B. Arpaci F, et al. Among authors: kuzhan o. J Clin Apher. 2004;19(4):197-201. doi: 10.1002/jca.20029. J Clin Apher. 2004. PMID: 15597344

10

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.

Arpaci F, Ataergin S, Ozet A, Erler K, Basbozkurt M, Ozcan A, Komurcu S, Ozturk B, Celasun B, Kilic S, Kuzhan O. Arpaci F, et al. Among authors: kuzhan o. Cancer. 2005 Sep 1;104(5):1058-65. doi: 10.1002/cncr.21279. Cancer. 2005. PMID: 15999369 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page